Literature DB >> 16574762

Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity.

Anne Valle1, Daniel T O'Connor, Palmer Taylor, Gu Zhu, Grant W Montgomery, P Eline Slagboom, Nicholas G Martin, John B Whitfield.   

Abstract

BACKGROUND: Plasma cholinesterase activity is known to be correlated with plasma triglycerides, HDL- and LDL-cholesterol, and other features of the metabolic syndrome. A role in triglyceride metabolism has been proposed. Genetic variants that decrease activity have been studied extensively, but the factors contributing to overall variation in the population are poorly understood. We studied plasma cholinesterase activity in a sample of 2200 adult twins to assess covariation with cardiovascular risk factors and components of the metabolic syndrome, to determine the degree of genetic effects on enzyme activity, and to search for quantitative trait loci affecting activity. METHODS AND
RESULTS: Cholinesterase activity was lower in women than in men before the age of 50, but increased to activity values similar to those in males after that age. There were highly significant correlations with variables associated with the metabolic syndrome: plasma triglyceride, HDL- and LDL-cholesterol, apolipoprotein B and E, urate, and insulin concentrations; gamma-glutamyltransferase and aspartate and alanine aminotransferase activities; body mass index; and blood pressure. The heritability of plasma cholinesterase activity was 65%. Linkage analysis with data from the dizygotic twin pairs showed suggestive linkage on chromosome 3 at the location of the cholinesterase (BCHE) gene and also on chromosome 5.
CONCLUSIONS: Our results confirm and extend the connection between cholinesterase, cardiovascular risk factors, and metabolic syndrome. They establish a substantial heritability for plasma cholinesterase activity that might be attributable to variation near the structural gene and at an independent locus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574762     DOI: 10.1373/clinchem.2005.065052

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins.

Authors:  Rohit Loomba; Fangwen Rao; Lian Zhang; Srikrishna Khandrika; Michael G Ziegler; David A Brenner; Daniel T O'Connor
Journal:  Gastroenterology       Date:  2010-06-09       Impact factor: 22.682

2.  Naturally occurring variations in the human cholinesterase genes: heritability and association with cardiovascular and metabolic traits.

Authors:  Anne M Valle; Zoran Radic; Brinda K Rana; Vafa Mahboubi; Jennifer Wessel; Pei-an Betty Shih; Fangwen Rao; Daniel T O'Connor; Palmer Taylor
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

Review 3.  Hereditary determinants of human hypertension: strategies in the setting of genetic complexity.

Authors:  Pei-an Betty Shih; Daniel T O'Connor
Journal:  Hypertension       Date:  2008-04-14       Impact factor: 10.190

4.  GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors.

Authors:  Beben Benyamin; Rita P Middelberg; Penelope A Lind; Anne M Valle; Scott Gordon; Dale R Nyholt; Sarah E Medland; Anjali K Henders; Andrew C Heath; Pamela A F Madden; Peter M Visscher; Daniel T O'Connor; Grant W Montgomery; Nicholas G Martin; John B Whitfield
Journal:  Hum Mol Genet       Date:  2011-08-23       Impact factor: 6.150

5.  Congenital hypothyroidism mutations affect common folding and trafficking in the α/β-hydrolase fold proteins.

Authors:  Antonella De Jaco; Noga Dubi; Shelley Camp; Palmer Taylor
Journal:  FEBS J       Date:  2012-11-01       Impact factor: 5.542

6.  Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder.

Authors:  Sadaf Munir; Rabia Habib; Sliha Awan; Nazia Bibi; Arooj Tanveer; Sajida Batool; Syed M Nurulain
Journal:  J Mol Neurosci       Date:  2019-02-01       Impact factor: 3.444

7.  The Correlative Study of Serum Pseudo-cholinesterase, Biological Parameters and Symptoms Among Occupational Workers.

Authors:  Tanasorn Tunsaringkarn; Kalaya Zapuang; Anusorn Rungsiyothin
Journal:  Indian J Clin Biochem       Date:  2013-04-03

8.  The cholinesterases: analysis by pharmacogenomics in man.

Authors:  A M Valle; Z Radić; B K Rana; J B Whitfield; D T O'Connor; N G Martin; P Taylor
Journal:  Chem Biol Interact       Date:  2008-05-04       Impact factor: 5.192

9.  Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits.

Authors:  Rita P S Middelberg; Manuel A R Ferreira; Anjali K Henders; Andrew C Heath; Pamela A F Madden; Grant W Montgomery; Nicholas G Martin; John B Whitfield
Journal:  BMC Med Genet       Date:  2011-09-24       Impact factor: 2.103

10.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.